Type 2 diabetes in association with HIV-1 protease inhibitors in HIV-infected patients.
Chronister
C L
CL
Gurwood
A S
AS
D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D003930:Diabetic Retinopathy / Q000139:chemically induced / Q000175:diagnosis; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D015497:HIV-1; D006801:Humans; D019469:Indinavir / Q000009:adverse effects; D019888:Nelfinavir / Q000009:adverse effects; D012160:Retina / Q000473:pathology; D012164:Retinal Diseases / Q000175:diagnosis / Q000821:virology; D019438:Ritonavir / Q000009:adverse effects; D019258:Saquinavir / Q000009:adverse effects
D017320:HIV Protease Inhibitors; D019469:Indinavir; D019888:Nelfinavir; D019258:Saquinavir; D019438:Ritonavir